Simpson Thacher is acting as U.S. counsel to EQT IX fund in connection with its acquisition of a 20% stake in 3Shape, a Copenhagen-based medical technology firm. The transaction is expected to close in first quarter of 2022.
Founded in 2000, 3Shape is a global leader in digital dentistry and provides state of the art intra-oral scanning solutions, Computer Aided Design and Computer Aided Manufacturing software for dentists and dental laboratories in over 100 countries.
EQT is a purpose-driven global investment organization with more than €70 billion in assets under management across 27 active funds. EQT funds have portfolio companies in Europe, Asia-Pacific and the Americas with total sales of approximately €29 billion and more than 175,000 employees. EQT works with portfolio companies to achieve sustainable growth, operational excellence and market leadership.
The Simpson Thacher team includes Michael T. Holick and Daniel Levien (Corporate); Vanessa Burrows and Tera Rule (U.S. Healthcare); Genevieve Dorment, Melanie Jolson and Sam Watters (Intellectual Property); David Rubinsky and Charles Pfeifer (Executive Compensation and Employee Benefits); Krista McManus and Timothy Gallagher (U.S. Real Estate); Mick Tuesley (Regulatory); Richard Jamgochian and Kelly Karapetyan (Antitrust); and Timothy Mulvihill (Environmental).